Opendoor stock jumps after SRx Health buy — what traders watch next

Opendoor stock jumps after SRx Health buy — what traders watch next

NEW YORK, Jan 18, 2026, 05:37 EST — Market closed.

  • Opendoor shares rose Friday following SRx Health Solutions’ announcement that it acquired the stock.
  • The investor kept the size of the position under wraps, prompting traders to hunt for official filings.
  • U.S. markets reopen Tuesday following the long weekend, with the rate outlook still driving volatility.

Opendoor Technologies Inc (OPEN.O) shares jumped 5.7% to close at $6.67 on Friday following an investment from SRx Health Solutions in the online homebuying company’s stock. Volume surged to roughly 68 million shares, with the price swinging between $6.32 and $6.92.

This shift is significant as Opendoor has once again become a headline-driven, rate-sensitive stock, with traders eager to pounce on any hint of renewed demand in housing-related shares.

This week feels a bit off. U.S. markets were closed Monday, giving investors an extra day to weigh if Friday’s rally signals a new trend or just a brief, one-day spike.

SRx, listed on NYSE American, said the purchase aligns with its capital allocation strategy to put excess liquidity into publicly traded securities, digital assets, and commodities it considers “undervalued.” The company added it might adjust its Opendoor stake up or down based on market conditions and valuation. Details on the investment size were not disclosed. 1

For Opendoor, this is mostly a signal in the short term. The statement didn’t mention any commercial deals, operational collaborations, or a role for SRx beyond being a shareholder.

Other housing-related stocks held steady. Zillow Group ticked up 0.9% on Friday, while Offerpad Solutions, also an iBuyer that purchases and flips homes, gained 0.7%.

Rates continue to hold sway. On Friday, Federal Reserve Vice Chair Philip Jefferson described the current policy stance as “well positioned” to adapt to fresh data, keeping the spotlight on the direction of borrowing costs. 2

U.S. markets will be shut Monday in observance of Martin Luther King, Jr. Day. The first major market action won’t kick off until trading picks back up on Tuesday. 3

The catalyst, however, comes with some caveats. Since no dollar amount was disclosed, it’s tough to assess how significant SRx’s purchase is for Opendoor’s shareholders. Plus, Opendoor’s model still faces inventory risk if home prices dip or funding costs rise sharply.

Traders are waiting for a filing revealing the size of the stake—U.S. regulations require disclosure once an investor passes the 5% threshold. They’re also looking for Opendoor to confirm its next earnings date. MarketBeat projects the report might drop on Feb. 26 but notes the company hasn’t officially set a date. 4

After Tuesday’s reopening, housing-sensitive stocks will be eyeing the Federal Reserve’s policy meeting on Jan. 27-28. The rate statement is set for Jan. 28 at 2:00 p.m. ET, followed by a press conference half an hour later. 5

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
London, Feb 7, 2026, 08:12 GMT — Market closed. Shares of GSK (GSK.L) ended Friday up 0.83% at 2,198 pence, a 52-week high, after the drugmaker said the European Commission approved Nucala for a form of chronic obstructive pulmonary disease (COPD). The stock is up about 17% over the past week and nearly 49% over the past year. 1 With London markets shut for the weekend, investors head into Monday weighing whether the regulatory win is enough to keep the rally going. Respiratory is a core franchise for GSK, and one where it fights for share against big peers including
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Super Micro Computer (SMCI) stock jumps 11% — what to watch after the long weekend
Previous Story

Super Micro Computer (SMCI) stock jumps 11% — what to watch after the long weekend

Grab stock (GRAB) steadies after HSBC upgrade as investors line up for Feb. 11 earnings
Next Story

Grab stock (GRAB) steadies after HSBC upgrade as investors line up for Feb. 11 earnings

Go toTop